---

The Menstrual Cycle - Complete Masterclass with Applied Pathology & Mnemonics

---

---

PART 1 - THE AXIS (The Master Control System)

HYPOTHALAMUS  →  PITUITARY  →  OVARY  →  UTERUS
    (General)    (Colonel)    (Major)   (Battlefield)

Hypothalamus - GnRH

• GnRH = Gonadotropin-Releasing Hormone (a decapeptide)
• Produced in the arcuate nucleus - embryologically migrates from the olfactory pit
• Must be secreted in a pulsatile fashion to work (continuous infusion = downregulation = no effect)
• Half-life only 2-4 minutes due to rapid proteolytic cleavage
• Pulse frequency differs by phase:
  • Follicular phase: frequent, small-amplitude pulses
  • Late follicular: increased frequency + amplitude (LH surge priming)
  • Luteal phase: progressive lengthening of intervals, high amplitude

Clinical pearl: Slow GnRH pulses → favor FSH; Fast pulses → favor LH. This is exploited pharmacologically - GnRH agonists given continuously (e.g., leuprolide) SUPPRESS LH/FSH, used in endometriosis, precocious puberty, and IVF downregulation.

• Pulsatile = necessary
• Oncontinuous = suppresses (downregulation)
• Nucleus arcuate = origin
• Decapeptide = structure

---

PART 2 - THE THREE PHASES (Overview)

---

PART 3 - FOLLICULAR PHASE (Days 1-14) - "ESTROGEN RULES"

What drives it?

• As the corpus luteum of the previous cycle degenerates → progesterone + inhibin A fall → FSH rises (freed from negative feedback)
• Rising FSH recruits a cohort of antral follicles

Folliculogenesis - "PPST" (Four Follicle Types)

1. Primordial - arrested oocyte + flat granulosa cells (0.03-0.05 mm)
2. Primary - cuboidal granulosa, zona pellucida forms (0.1 mm) - first FSH receptors appear
3. Secondary - multi-layered granulosa, theca cells differentiate with LH receptors, neoangiogenesis (0.2 mm)
4. Tertiary (antral) → Graafian (dominant) - fluid-filled antrum, most FSH receptors

The Two-Cell, Two-Gonadotropin Theory

LH → THECA CELLS → Androgens (androstenedione, testosterone)
           ↓ (diffuse into granulosa)
FSH → GRANULOSA CELLS → Aromatase → Estrogens (estradiol)

• Theca produces androgens under LH; Granulosa converts them to estrogen under FSH
• Dominant follicle wins by having the most FSH receptors → produces more estrogen → survives even as FSH drops

Endometrial Changes (Proliferative)

• Estradiol → endometrial growth, gland elongation, spiral arteries elongate
• Cervical mucus: copious, watery, elastic, "ferning" pattern on glass slide (channels form that allow sperm penetration)

• Growth of endometrium
• Cervical mucus watery (ferning, sperm-friendly)
• Spiral arteries elongate
• Endometrial glands elongate

---

PART 4 - OVULATION (Day 14)

Trigger Sequence:

1. Dominant follicle's rising estradiol reaches a threshold (~200 pg/mL for >36 hrs)
2. Positive feedback switch: estrogen now stimulates GnRH → FSH + LH surge
3. LH surge → ovulation within 36-40 hours
4. LH disrupts gap junctions between granulosa cells and oocyte → meiosis I resumes (was arrested in dictyate/diplotene stage of prophase I since fetal life)
5. Egg released as secondary oocyte (meiosis II completes only if fertilized)

• Positive feedback from estradiol peak
• LH surge triggers ovulation
• Oocyte resumes meiosis (exits prophase I arrest)
• Temperature (basal body temperature rises 0.5°C after ovulation due to progesterone - thermogenic)

Signs of Ovulation (Clinically Useful)

• Mittelschmerz - mid-cycle pelvic pain (follicle rupture)
• Basal body temperature RISES (progesterone is thermogenic)
• Cervical mucus becomes watery and shows "ferning" (pre-ovulation estrogen peak)
• LH urine surge detectable 24h before ovulation (basis of OPKs)

---

PART 5 - LUTEAL/SECRETORY PHASE (Days 14-28)

Corpus Luteum Formation

• Granulosa and theca cells luteinize under LH → corpus luteum
• Produces: Progesterone (dominant) + Estradiol + Inhibin A
• Corpus luteum survives 12-16 days if no pregnancy; then → corpus albicans (fibrous scar)

Progesterone's Actions (Secretory Phase):

• Secretory transformation of endometrium (glands tortuous, glycogen vacuoles, increased mucus)
• Temperature rises (hypothalamic set point elevated - thermogenic)
• Arteries become coiled (spiral arteries hypertrophy)
• Blocking cervical mucus (thick, non-elastic, non-ferning - now sperm-hostile)
• Contractility of uterus decreases (maintains implantation environment)

What happens if NO pregnancy:

• Corpus luteum regresses → progesterone + estradiol fall → endometrial ischemia → menstruation
• Mechanism: spiral artery vasoconstriction (mediated by prostaglandins) → ischemia → necrosis → sloughing = menses

What happens if PREGNANCY occurs:

• Implanting trophoblast secretes hCG (mimics LH) → rescues corpus luteum
• Corpus luteum maintains progesterone until luteal-placental shift (~5-7 weeks gestation)

---

PART 6 - FEEDBACK LOOPS (MUST KNOW)

This is unique - estrogen can do BOTH positive and negative feedback depending on level and duration. That's why combined OCP (high constant estrogen + progestin) = sustained negative feedback = no LH surge = no ovulation.

---

PART 7 - APPLIED PATHOLOGY (The Clinical Payoff)

FRAMEWORK: PALM-COEIN Classification for Abnormal Uterine Bleeding (AUB)

PALM = Structural causes          COEIN = Non-structural causes
P - Polyp                         C - Coagulopathy
A - Adenomyosis                   O - Ovulatory dysfunction
L - Leiomyoma (SM vs Other)       E - Endometrial
M - Malignancy/Hyperplasia        I - Iatrogenic
                                  N - Not yet classified

---

STRUCTURAL CAUSES (PALM)

P - Polyps

• Focal endometrial/cervical overgrowths
• Cause: intermenstrual spotting, menorrhagia
• Diagnosis: sonohysterography, hysteroscopy
• Associated with: unopposed estrogen, tamoxifen use

A - Adenomyosis

• Endometrial glands/stroma within myometrium (not outside uterus - that's endometriosis)
• Causes: dysmenorrhea + menorrhagia + globular "boggy" uterus
• Mnemonic: "Adenomyosis = Endo IN the muscle" (vs Endometriosis = Endo OUTSIDE)
• Diagnosis: MRI (gold standard), USS (junctional zone >12mm)

L - Leiomyoma (Fibroids)

• Submucosal > intramural > subserosal for causing bleeding
• Submucosal fibroids distort the cavity → most symptomatic bleeding
• Estrogen-dependent (grow in reproductive years, regress post-menopause)

M - Malignancy/Hyperplasia

• Most common cancer of female genital tract in high-income countries = endometrial carcinoma
• Two pathways:

• Obesity (adipose tissue converts androgens → estrogens via aromatase)
• PCOS
• Early menarche/late menopause
• Nulliparity
• Diabetes/metabolic syndrome
• Ovarian tumors (granulosa-theca cell - estrogen-producing)
• Exogenous estrogen (unopposed)
• Sterility

• Without atypia: 1-3% risk of progression to carcinoma
• With atypia (EIN - Endometrial Intraepithelial Neoplasia): HIGH risk, carries PTEN mutations - same as carcinoma
• Treatment: atypia → hysterectomy (or progestins if fertility desired)

---

NON-STRUCTURAL CAUSES (COEIN)

C - Coagulopathy

• Up to 20% of women with heavy menstrual bleeding have an underlying coagulopathy
• Von Willebrand disease = most common (up to 13% of AUB cases)
• Often presents at menarche with first heavy period
• Screen: family history of bleeding disorders, easy bruising, gum bleeding

O - Ovulatory Dysfunction

• Hyperprolactinemia (prolactin suppresses GnRH → low LH/FSH)
• Endocrine (thyroid disease, adrenal disorders)
• Androgenic excess / Anorexia nervosa / any systemic illness
• PCOS (most common in reproductive age)

PCOS (Polycystic Ovary Syndrome)

• Hyperandrogenism (clinical: hirsutism, acne; or biochemical: elevated androgens)
• Anovulation (oligomenorrhea/amenorrhea)
• Ovary appearance (polycystic on USS: >12 follicles 2-9mm OR volume >10 mL)

↑LH:FSH ratio
   → ↑Theca androgen production
      → Partial aromatization → ↑Estrone (constant, not cyclic)
         → Positive feedback on LH, negative on FSH
            → More androgen, less FSH → follicle arrest → anovulation

E - Endometrial (Primary endometrial dysfunction)

• Defects in local endometrial hemostatic mechanisms
• Normal ovulatory cycles but abnormal bleeding
• Mechanism: impaired prostaglandin balance, deficient tissue factor expression

I - Iatrogenic

• Hormonal contraceptives (breakthrough bleeding, especially progestin-only)
• IUDs (copper → heavy bleeding; levonorgestrel IUD → amenorrhea)
• Anticoagulants
• Post-cesarean scar defect (isthmocele)

---

PART 8 - ENDOMETRIOSIS (Special Topic)

1. Ovaries (most common - "chocolate cysts")
2. Uterine ligaments
3. Ligament (rectovaginal septum)
4. Rectovaginal septum
5. Cul de sac
6. Serosa of bowel/appendix
7. Mucosa of cervix/vagina
8. Laparotomy scars

• Dysmenorrhea (painful periods - cyclical pelvic pain)
• Infertility
• Pelvic pain (chronic)

1. Regurgitation (Sampson's theory) - retrograde menstruation → implantation
2. Embolism (benign metastasis) - lymphatic/vascular spread
3. Metaplasia - coelomic epithelium → endometrium
4. Stem cells - bone marrow-derived progenitors

---

PART 9 - TERMINOLOGY QUICK REFERENCE (For Diagnosis)

• Turner syndrome (45,X) - commonest chromosomal cause
• Outflow tract obstruction (imperforate hymen, vaginal atresia)
• Gonadal dysgenesis (other)
• Androgen insensitivity syndrome (46,XY - complete AIS)

• Pregnancy (ALWAYS rule out first!)
• Hypothalamic dysfunction (stress, weight loss, exercise - "functional hypothalamic amenorrhea")
• Anterior pituitary (hyperprolactinemia, Sheehan's syndrome, tumors)
• Thyroid / adrenal disease
• PCOS / premature ovarian insufficiency

---

PART 10 - CLINICAL DIAGNOSTIC APPROACH TO AUB

• Adolescent: coagulation screen (VWD), hormonal workup
• Reproductive: USS (fibroids, polyps), hormonal panel (FSH, LH, TSH, prolactin, androgens)
• Perimenopausal: endometrial biopsy if >45 years or risk factors
• Postmenopausal: endometrial biopsy + USS (endometrial thickness >4mm = investigate)

---

MASTER SUMMARY TABLE

---

FINAL MNEMONICS CHEAT SHEET

---

---

PART 1 - THE H-P-O-U AXIS (Deep Dive)

---

The 4-Level Hierarchy

HYPOTHALAMUS
     ↓ GnRH (portal blood)
  PITUITARY
     ↓ FSH + LH (systemic blood)
    OVARY
     ↓ Estrogen + Progesterone + Inhibin
   UTERUS (end organ)

---

Level 1 - Hypothalamus

GnRH - The Master Switch

• Full name: Gonadotropin-Releasing Hormone (also called LHRH)
• Structure: Decapeptide (10 amino acids)
• Origin: Arcuate nucleus of the hypothalamus
• Embryology: GnRH neurons originate in the olfactory pit and migrate to the arcuate nucleus during fetal life

Clinical pearl - Kallmann Syndrome: Failure of GnRH neurons to migrate from olfactory pit → hypogonadotropic hypogonadism + anosmia. Patient has no periods AND cannot smell. The link between smell and reproduction is because of this shared embryological origin.

The Pulsatile Imperative

GnRH Pulse Frequency Across the Cycle

Slow pulses → favor FSH; Fast pulses → favor LH This is why in the late luteal phase (slow pulses), FSH quietly rises to begin recruiting the next cohort of follicles even BEFORE the current period begins.

What modulates GnRH?

• Kisspeptin (from KNDy neurons in arcuate nucleus) is the primary stimulator of GnRH release
• Kisspeptin neurons also respond to estrogen feedback - this is HOW estrogen both suppresses AND surges GnRH depending on level
• Neurokinin B (stimulates kisspeptin) and Dynorphin (inhibits kisspeptin) also modulate the system

• Stress → CRH → cortisol → suppresses GnRH (explains amenorrhea in athletes/anorexics)
• Prolactin excess → suppresses GnRH (explains amenorrhea with hyperprolactinemia, and lactational amenorrhea)
• Opioids (endogenous and exogenous) → suppress GnRH pulses
• High estrogen + progesterone (combined OCP) → negative feedback

---

Level 2 - Anterior Pituitary

FSH and LH - Structure & Differences

• Identical α-subunit (shared with TSH and hCG - this is why hCG can mimic LH!)
• Unique β-subunit (determines specificity)

The LH Surge - Mechanism

Estradiol peak
    ↓
GnRH pulse amplitude ↑ (positive feedback via kisspeptin)
    ↓
Massive LH release (10-fold rise within 36-48h)
    ↓
Ovulation ~36-40 hours later

• At low levels: estrogen inhibits kisspeptin → suppresses GnRH
• At high, sustained levels: estrogen upregulates kisspeptin receptors in the hypothalamus AND directly upregulates LH receptors in pituitary gonadotrophs → positive feedback kicks in

---

Level 3 - Ovary

Inhibins - The Fine-Tuners

Ovarian Disorders at the Axis Level

The most important diagnostic principle: FSH level tells you WHERE the problem is:

• FSH low = problem is above the ovary (hypothalamus or pituitary) = hypogonadotropic hypogonadism
• FSH high = problem is at the ovary level (ovarian failure) = hypergonadotropic hypogonadism

---

Level 4 - Uterus (End Organ)

• Normal FSH, LH, estrogen - axis is fine
• But endometrium is scarred and cannot respond
• Presents as secondary amenorrhea after D&C or postpartum hemorrhage
• Diagnosis: hysteroscopy (gold standard)
• Treatment: hysteroscopic adhesiolysis + estrogen therapy to re-grow endometrium

---

PART 3 - FOLLICULAR PHASE (Deep Dive)

---

Timeline: What Happens Day by Day

Days 1-5 (Menstruation + Early Recruitment)

• Corpus luteum of previous cycle → dead → progesterone + inhibin A fall
• FSH escapes suppression and rises - this rise happens even BEFORE the period ends
• FSH recruits a cohort of antral follicles (5-10 follicles awakened from their resting state)
• Each recruited follicle is a "tertiary/antral" follicle (already developed over the previous 3 months in a gonadotropin-independent phase)

Important: Folliculogenesis from primordial to antral takes about 85 days total. The "follicular phase" we see clinically is only the final 14-day FSH-dependent selection period.

Days 5-9 (Follicular Selection)

• All recruited follicles grow under FSH stimulation
• Each produces increasing estradiol
• Rising estradiol → negative feedback → FSH starts falling again
• Only the follicle with the most FSH receptors and best local estrogen environment survives the FSH decline = DOMINANT FOLLICLE
• All others undergo atresia (apoptosis of granulosa cells)

Days 9-14 (Dominant Follicle Growth)

• Dominant (Graafian) follicle continues to grow (up to 20-25mm)
• Produces surging estradiol
• LH receptors appear on granulosa cells (FSH-induced) → granulosa cells can now respond directly to the LH surge

---

Folliculogenesis - 5 Stages in Detail

1. Primordial Follicle

• Size: 0.03-0.05mm
• Structure: primary oocyte (arrested in prophase I of meiosis I, diplotene/dictyate stage) + single layer of flattened granulosa cells + basal lamina
• Status: dormant, no FSH receptors, no blood supply
• Numbers: ~1-2 million at birth → ~300,000-400,000 at puberty → ~1,000 at menopause
• Meiotic arrest maintained by: oocyte maturation inhibitor (OMI) from granulosa, granulosa-derived cAMP transmitted via gap junctions (connexins)

2. Primary Follicle

• Granulosa cells become cuboidal (first sign of activation/recruitment)
• Zona pellucida begins to form (extracellular glycoprotein matrix between oocyte and granulosa)
• Gap junctions (connexins) connect oocyte and granulosa
• FSH receptors appear on granulosa - but no effect yet (no vasculature)

3. Secondary Follicle

• Multiple layers of cuboidal granulosa cells
• Theca cells differentiate from stromal cells → express LH receptors
• Neoangiogenesis occurs in theca layer → follicle now exposed to circulating FSH and LH
• Two-cell two-gonadotropin system now operational

4. Tertiary (Antral) Follicle

• Antrum forms - fluid-filled space (follicular fluid = plasma filtrate + granulosa secretions, rich in estrogen)
• Cumulus oophorus - granulosa cells surrounding oocyte (projecting into antrum)
• Mural granulosa cells - line the follicle wall
• Fully FSH-dependent from this point

5. Graafian (Dominant) Follicle

• Size: 20-25mm pre-ovulation
• Massive estradiol production
• LH receptors appear on granulosa cells (FSH-induced) → ready for LH surge
• Oocyte is still arrested in prophase I until the LH surge disrupts gap junctions

---

The Two-Cell, Two-Gonadotropin Theory - In Detail

+-----------------------------+    +--------------------------------+
|       THECA CELL            |    |       GRANULOSA CELL           |
|  (has LH receptors)         |    |  (has FSH receptors)           |
|                             |    |                                |
|  Cholesterol                |    |                                |
|      ↓ (LH)                 |    |                                |
|  Pregnenolone               |    |  Receives androstenedione      |
|      ↓                      | →→→|       ↓ (FSH → aromatase)     |
|  Progesterone               |    |  ESTRADIOL (E2)                |
|      ↓                      |    |                                |
|  Androstenedione            |    |                                |
|  Testosterone               |    |                                |
+-----------------------------+    +--------------------------------+

• Theca cells CANNOT aromatize (no aromatase) → they can only make androgens
• Granulosa cells CANNOT make androgens (no 17α-hydroxylase) → they need theca's androgens as substrate
• Both cell types are needed - neither can produce estrogen alone

• FSH deficiency → no aromatase induction → no estrogen despite LH being normal
• LH deficiency → no androgens → no substrate for aromatase → no estrogen
• Granulosa cell tumors → make estrogen directly → hyperestrogenism → precocious puberty in girls, endometrial hyperplasia in women

---

Estradiol's Actions in the Follicular Phase - Expanded

On the Endometrium (Proliferative Phase)

• Stimulates endometrial gland elongation
• Promotes stromal growth
• Elongates spiral arteries
• Increases endometrial thickness (from ~1mm at menses to ~8-12mm at ovulation)
• Induces progesterone receptors on endometrium (preparing it to respond to luteal progesterone)

On the Cervix

• Mucus becomes: copious, watery, clear, elastic
• Ferning pattern on glass slide (NaCl crystallization in estrogen-rich mucus)
• Spinnbarkeit = stretchability of cervical mucus (up to 6-8cm at ovulation)
• Cervical os opens slightly

On Pituitary/Hypothalamus

• Low levels → negative feedback (suppresses FSH/LH)
• High sustained levels → positive feedback (triggers LH surge)

On Other Systems

• Increases hepatic production of SHBG (sex hormone binding globulin) → binds androgens → reduces free testosterone (explains why combined OCP reduces hirsutism in PCOS)
• Promotes bone density (osteoblast stimulation, osteoclast inhibition)
• Cardiovascular protection (vasodilation, favorable lipid profile)
• Increases coagulation factors (V, VII, VIII, X, fibrinogen) → explains VTE risk with OCPs

---

Why the Follicular Phase Length Varies (Clinical Importance)

• How quickly a dominant follicle develops
• FSH levels (higher FSH = faster recruitment)
• Ovarian reserve (fewer follicles = slower recruitment = longer follicular phase in perimenopause)
• Stress, illness, medications (can delay or prevent ovulation)

Clinical use: If a woman has a 35-day cycle, she ovulates on day ~21. If you want to do a progesterone test to confirm ovulation, draw it on day 28 (7 days after presumed ovulation, i.e., luteal mid-point). A level >3 ng/mL confirms ovulation; >10 ng/mL = adequate luteal function.

---

Follicular Phase Pathology Summary

---

Final Mnemonic Summary for Parts 1 & 3